Baker Tilly engaged William Blair & Company, L.L.C. as its financial advisor and Foley & Lardner LLP as its legal counsel on this transaction. Simpson Thacher...
Baker Tilly’s Capital Raise
Bain Capital Credit’s Closing of Middle Market Credit Fund at $1 Billion
Ropes & Gray advised Bain Capital Credit, L.P. in the deal. Bain Capital Credit, L.P. announced the closing of Bain Capital Middle Market Credit 2022 (together with...
Forest River Bus’ $303 Million Acquisition of Collins Bus Corporation
Ropes & Gray advised REV Group, Inc. on the transaction. Forest River Bus, LLC., a subsidiary of Forest River, Inc. and the nation’s leading shuttle bus...
Haveli Investments’ $350 Million Acquisition of ZeroFox Holdings
Ropes & Gray advised Haveli Investments on the transaction, and Venable advised ZeroFox Holdings, Inc. ZeroFox Holdings, Inc. (Nasdaq: ZFOX) (“ZeroFox”), a leading provider of external...
Chartis’ Acquisition of HealthScape Advisors
Ropes & Gray represented Chartis in the transaction. Chartis, a portfolio company of Audax Group, announced its acquisition of HealthScape Advisors, a leading healthcare payer consulting firm....
Celsius Network’s Chapter 11 Exit and Distribution of Over US$3 Billion of Cryptocurrency to Creditors
White & Case LLP has advised the Official Committee of Unsecured Creditors of Celsius Network, LLC (the “Committee”) on the successful confirmation of Celsius Network’s chapter...
Altice USA’s $2.05 Billion Guaranteed Notes Offering
Ropes & Gray has advised Altice USA, while Paul Hastings LLP advised Goldman Sachs. Altice USA (NYSE:ATUS) issued $2.05 billion Senior Guaranteed Notes due 2029 by its...
Surgery Partners’ $2.1 Billion Refinancing
Ropes & Gray represented Surgery Partners Inc. in the deal. Paul Hastings LLP advised Jefferies and other joint lead arrangers. Surgery Partners Inc. (NASDAQ:SGRY), a short-stay...
MOMA Therapeutics’ Collaboration and Licensing Agreement with Roche
Ropes & Gray advised MOMA Therapeutics on the deal. MOMA Therapeutics announced a collaboration and licensing agreement with Swiss pharmaceutical leader Roche (SIX: RO, ROG; OTCQX: RHHBY)....
Allorion Therapeutics’ Licensing Agreement with Avenzo Therapeutics
Ropes & Gray advised Allorion Therapeutics on the transaction. Allorion Therapeutics (Allorion) announced it entered into a global licensing agreement with Avenzo Therapeutics Inc. (Avenzo) to develop and...
AbbVie’s Collaboration with Umoja Biopharma
Ropes & Gray advised AbbVie on the deal. AbbVie (NYSE: ABBV), and Umoja Biopharma (Umoja) Umoja Biopharma announced two exclusive option and license agreements to develop multiple in-situ...
Virginia Green’s Recapitalization
Harris Williams served as financial advisor and Williams Mullen served as legal advisor to Virginia Green. TD Cowen served as financial advisor and Paul, Weiss, Rifkind,...